117 related articles for article (PubMed ID: 30441662)
1. Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies.
Braoudaki M; Koutsouris DD; Kouris I; Paidi A; Koutsouri G; George Lambrou I
Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5834-5837. PubMed ID: 30441662
[TBL] [Abstract][Full Text] [Related]
2. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis Reveals Ki-67 Specific microRNA Functions in Pediatric Embryonal Tumors.
Braoudaki M; Sarafidis M; Koutsouris DD; Koutsouri G; Lambrou GI
Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():1346-1349. PubMed ID: 31946142
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown.
Braoudaki M; Lambrou GI
J Hematol Oncol; 2015 Feb; 8():6. PubMed ID: 25652781
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA signatures as biomarkers and therapeutic target for CNS embryonal tumors: the pros and the cons.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Int J Mol Sci; 2014 Nov; 15(11):21554-86. PubMed ID: 25421247
[TBL] [Abstract][Full Text] [Related]
6. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
[TBL] [Abstract][Full Text] [Related]
7. Significance and therapeutic value of miRNAs in embryonal neural tumors.
Shalaby T; Fiaschetti G; Baumgartner M; Grotzer MA
Molecules; 2014 May; 19(5):5821-62. PubMed ID: 24806581
[TBL] [Abstract][Full Text] [Related]
8. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas.
Braoudaki M; Lambrou GI; Giannikou K; Papadodima SA; Lykoudi A; Stefanaki K; Sfakianos G; Kolialexi A; Tzortzatou-Stathopoulou F; Tzetis M; Kitsiou-Tzeli S; Kanavakis E
Tumour Biol; 2016 Jul; 37(7):9887-97. PubMed ID: 26813564
[TBL] [Abstract][Full Text] [Related]
9. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
10. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
11. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.
Wang HW; Wu YH; Hsieh JY; Liang ML; Chao ME; Liu DJ; Hsu MT; Wong TT
BMC Genomics; 2010 Feb; 11():132. PubMed ID: 20178649
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Testicular Cancer Diagnosis and Prognosis.
Ling H; Krassnig L; Bullock MD; Pichler M
Urol Clin North Am; 2016 Feb; 43(1):127-34. PubMed ID: 26614035
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors.
Braoudaki M; Lambrou GI; Papadodima SA; Stefanaki K; Prodromou N; Kanavakis E
Med Oncol; 2016 Jan; 33(1):5. PubMed ID: 26698155
[TBL] [Abstract][Full Text] [Related]
14. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of SUN2, a novel tumor suppressor, mediates miR-221/222-induced malignancy in central nervous system embryonal tumors.
Hsieh TH; Chien CL; Lee YH; Lin CI; Hsieh JY; Chao ME; Liu DJ; Chu SS; Chen W; Lin SC; Ho DM; Liu RS; Lin CH; Wong TT; Wang HW
Carcinogenesis; 2014 Oct; 35(10):2164-74. PubMed ID: 24832085
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
17. Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.
Zhang X; Peng Y; Jin Z; Huang W; Cheng Y; Liu Y; Feng X; Yang M; Huang Y; Zhao Z; Wang L; Wei Y; Fan X; Zheng D; Meltzer SJ
Oncotarget; 2015 Oct; 6(32):32878-89. PubMed ID: 26460735
[TBL] [Abstract][Full Text] [Related]
18. Co-Deregulated miRNA Signatures in Childhood Central Nervous System Tumors: In Search for Common Tumor miRNA-Related Mechanics.
Lambrou GI; Zaravinos A; Braoudaki M
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204289
[TBL] [Abstract][Full Text] [Related]
19. Levels of MicroRNA Heterogeneity in Cancer Biology.
Petrovic N; Ergün S; Isenovic ER
Mol Diagn Ther; 2017 Oct; 21(5):511-523. PubMed ID: 28620889
[TBL] [Abstract][Full Text] [Related]
20. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]